Literature DB >> 29360923

First report of overall survival for ipilimumab plus nivolumab from the phase III Checkmate 067 study in advanced melanoma.

S Turajlic1, M Gore2, J Larkin3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29360923     DOI： 10.1093/annonc/mdy020

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

1.  Proautoimmune Allele of Tyrosine Phosphatase, PTPN22, Enhances Tumor Immunity.

Authors:  Robin C Orozco; Kristi Marquardt; Kerri Mowen; Linda A Sherman
Journal:  J Immunol       Date:  2021-08-20       Impact factor: 5.422

2.  Establishment of a 5-gene risk model related to regulatory T cells for predicting gastric cancer prognosis.

Authors:  Gang Hu; Ningjie Sun; Jiansong Jiang; Xiansheng Chen
Journal:  Cancer Cell Int       Date:  2020-09-03       Impact factor: 5.722

3.  The Dosage of the Derivative of Clostridium Ghonii (DCG) Spores Dictates Whether an IFNγ/IL-9 or a Strong IFNγ Response Is Elicited in TC-1 Tumour Bearing Mice.

Authors:  Guoying Ni; Yong Wang; David Good; Jianwei Yuan; Xuan Pan; Jou Wei; Xiaosong Liu; Ming Q Wei
Journal:  Biomed Res Int       Date:  2019-04-28       Impact factor: 3.411

4.  Invariant NKT Cell-Mediated Modulation of ILC1s as a Tool for Mucosal Immune Intervention.

Authors:  Stephanie Trittel; Neha Vashist; Thomas Ebensen; Benedict J Chambers; Carlos A Guzmán; Peggy Riese
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

Review 5.  PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake.

Authors:  Jian-Ye Zhang; Yan-Yan Yan; Jia-Jun Li; Rameshwar Adhikari; Li-Wu Fu
Journal:  Front Pharmacol       Date:  2020-05-15       Impact factor: 5.810

Review 6.  The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy.

Authors:  Haoyu Sun; Cheng Sun
Journal:  Front Immunol       Date:  2019-10-17       Impact factor: 7.561

Review 7.  Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma.

Authors:  Otto Luiz Dutra Cerqueira; Fernanda Antunes; Nadine G Assis; Elaine C Cardoso; Maria A Clavijo-Salomón; Ana C Domingues; Nayara G Tessarollo; Bryan E Strauss
Journal:  Front Mol Biosci       Date:  2022-04-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.